Correlation Between Iovance Biotherapeutics and CytomX Therapeutics
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and CytomX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and CytomX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and CytomX Therapeutics, you can compare the effects of market volatilities on Iovance Biotherapeutics and CytomX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of CytomX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and CytomX Therapeutics.
Diversification Opportunities for Iovance Biotherapeutics and CytomX Therapeutics
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Iovance and CytomX is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and CytomX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CytomX Therapeutics and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with CytomX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CytomX Therapeutics has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and CytomX Therapeutics go up and down completely randomly.
Pair Corralation between Iovance Biotherapeutics and CytomX Therapeutics
Given the investment horizon of 90 days Iovance Biotherapeutics is expected to generate 1.66 times less return on investment than CytomX Therapeutics. But when comparing it to its historical volatility, Iovance Biotherapeutics is 2.54 times less risky than CytomX Therapeutics. It trades about 0.05 of its potential returns per unit of risk. CytomX Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 139.00 in CytomX Therapeutics on September 14, 2024 and sell it today you would lose (28.00) from holding CytomX Therapeutics or give up 20.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Iovance Biotherapeutics vs. CytomX Therapeutics
Performance |
| Timeline |
| Iovance Biotherapeutics |
| CytomX Therapeutics |
Iovance Biotherapeutics and CytomX Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Iovance Biotherapeutics and CytomX Therapeutics
The main advantage of trading using opposite Iovance Biotherapeutics and CytomX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, CytomX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will offset losses from the drop in CytomX Therapeutics' long position.| Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
| CytomX Therapeutics vs. Puma Biotechnology | CytomX Therapeutics vs. Iovance Biotherapeutics | CytomX Therapeutics vs. Day One Biopharmaceuticals | CytomX Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |